Cargando…
Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
4CMenB is the first broad coverage vaccine for the prevention of invasive meningococcal disease caused by serogroup B strains. To gain a comprehensive picture of the antibody response induced upon 4CMenB vaccination and to obtain relevant translational information directly from human studies, we hav...
Autores principales: | Giuliani, M., Bartolini, E., Galli, B., Santini, L., Lo Surdo, P., Buricchi, F., Bruttini, M., Benucci, B., Pacchiani, N., Alleri, L., Donnarumma, D., Pansegrau, W., Peschiera, I., Ferlenghi, I., Cozzi, R., Norais, N., Giuliani, M. M., Maione, D., Pizza, M., Rappuoli, R., Finco, O., Masignani, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829249/ https://www.ncbi.nlm.nih.gov/pubmed/29487324 http://dx.doi.org/10.1038/s41598-018-22057-7 |
Ejemplares similares
-
Structural basis for cooperativity of human monoclonal antibodies to meningococcal factor H-binding protein
por: Peschiera, Ilaria, et al.
Publicado: (2019) -
Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity
por: Bartolini, E., et al.
Publicado: (2020) -
The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
por: Masignani, Vega, et al.
Publicado: (2019) -
Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6
por: Bianchi, Federica, et al.
Publicado: (2019) -
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp
por: Veggi, Daniele, et al.
Publicado: (2020)